BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi S, Yu X. Selecting chemotherapy for pancreatic cancer: Far away or so close? Semin Oncol 2019;46:39-47. [PMID: 30611527 DOI: 10.1053/j.seminoncol.2018.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim SS, Lee S, Lee HS, Bang S, Park MS. Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy. Abdom Radiol (NY) 2021;46:655-66. [PMID: 32748250 DOI: 10.1007/s00261-020-02661-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Huang L, Han J, Yu H, Liu J, Gui L, Wu Z, Zhao X, Su S, Fu G, Li F. CircRNA_000864 Upregulates B-cell Translocation Gene 2 Expression and Represses Migration and Invasion in Pancreatic Cancer Cells by Binding to miR-361-3p. Front Oncol 2020;10:547942. [PMID: 33425718 DOI: 10.3389/fonc.2020.547942] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kim SS, Lee S, Seung Lee H, Bang S, Han K, Park MS. Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9. Radiology 2022;:212236. [PMID: 35258374 DOI: 10.1148/radiol.212236] [Reference Citation Analysis]
4 Zhang L, Wang Y, Zhang L, You G, Li C, Meng B, Zhou M, Zhang M. LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p/HOXB8 axis. Cancer Cell Int 2019;19:320. [PMID: 31827394 DOI: 10.1186/s12935-019-1036-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cura Daball P, Tröger H, Daum S. [Long-term response in advanced pancreatic adenocarcinoma - a case report and literature review]. Z Gastroenterol 2021. [PMID: 34905798 DOI: 10.1055/a-1695-3528] [Reference Citation Analysis]
6 Indellicato R, Zulueta A, Caretti A, Trinchera M. Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale Towards A Personalized Clinical Application. Cancers (Basel) 2020;12:E1509. [PMID: 32527016 DOI: 10.3390/cancers12061509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Rapposelli IG, Casadei-Gardini A, Vivaldi C, Bartolini G, Bernardini L, Passardi A, Frassineti GL, Massa V, Cucchetti A. Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer. Biomolecules 2021;11:780. [PMID: 34067288 DOI: 10.3390/biom11060780] [Reference Citation Analysis]